Benefit-risk analysis of health benefits of routine childhood immunisation against the excess risk of SARS-CoV-2 infections during the COVID-19 pandemic in Africa
View ORCID ProfileKaja Abbas, View ORCID ProfileSimon R Procter, View ORCID ProfileKevin van Zandvoort, Andrew Clark, View ORCID ProfileSebastian Funk, LSHTM CMMID CMMID COVID-19 Working Group, Tewodaj Mengistu, Dan Hogan, Emily Dansereau, View ORCID ProfileMark Jit, View ORCID ProfileStefan Flasche
doi: https://doi.org/10.1101/2020.05.19.20106278
Kaja Abbas
1London School of Hygiene & Tropical Medicine
Simon R Procter
1London School of Hygiene & Tropical Medicine
Kevin van Zandvoort
1London School of Hygiene & Tropical Medicine
Andrew Clark
1London School of Hygiene & Tropical Medicine
Sebastian Funk
1London School of Hygiene & Tropical Medicine
1London School of Hygiene & Tropical Medicine
Tewodaj Mengistu
2Gavi, the Vaccine Alliance
Dan Hogan
2Gavi, the Vaccine Alliance
Emily Dansereau
3Bill & Melinda Gates Foundation
Mark Jit
1London School of Hygiene & Tropical Medicine
4Public Health England
5University of Hong Kong
Stefan Flasche
1London School of Hygiene & Tropical Medicine
Data Availability
The program code and data for the benefit-risk analysis conducted in this study is accessible on GitHub (https://github.com/vaccine-impact/epi_covid).
Posted June 24, 2020.
Benefit-risk analysis of health benefits of routine childhood immunisation against the excess risk of SARS-CoV-2 infections during the COVID-19 pandemic in Africa
Kaja Abbas, Simon R Procter, Kevin van Zandvoort, Andrew Clark, Sebastian Funk, LSHTM CMMID CMMID COVID-19 Working Group, Tewodaj Mengistu, Dan Hogan, Emily Dansereau, Mark Jit, Stefan Flasche
medRxiv 2020.05.19.20106278; doi: https://doi.org/10.1101/2020.05.19.20106278
Benefit-risk analysis of health benefits of routine childhood immunisation against the excess risk of SARS-CoV-2 infections during the COVID-19 pandemic in Africa
Kaja Abbas, Simon R Procter, Kevin van Zandvoort, Andrew Clark, Sebastian Funk, LSHTM CMMID CMMID COVID-19 Working Group, Tewodaj Mengistu, Dan Hogan, Emily Dansereau, Mark Jit, Stefan Flasche
medRxiv 2020.05.19.20106278; doi: https://doi.org/10.1101/2020.05.19.20106278
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2318)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11653)
- Forensic Medicine (10)
- Gastroenterology (688)
- Genetic and Genomic Medicine (3656)
- Geriatric Medicine (344)
- Health Economics (625)
- Health Informatics (2341)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3407)
- Nursing (193)
- Nutrition (512)
- Oncology (1788)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (442)
- Pediatrics (1015)
- Primary Care Research (411)
- Public and Global Health (6047)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (392)
- Toxicology (50)
- Transplantation (171)
- Urology (144)